Patrick W. Domkowski, G. Chad Hughes, John E. Scarborough, Luis H. Diodato, Monica L. Smith, Kevin P. Landolfo, and James E. Lowe
Transmyocardial laser revascularization (TMR) is emerging as a potential treatment option for path end-stage coronary artery disease who are not candidates for coronary
angioplasty or bypass surgery.
Become a member of OSA or log in to view the full text of this article.
OSA Members get the full text of Optics & Photonics News, plus a variety of other member benefits.